CEF26, Influenza Virus NP (265-274)

CEF26 is a synthetic HLA-A*03-restricted epitope derived from influenza virus nucleoprotein, corresponding to residues 265–274. This peptide is widely used in viral immunology to evaluate antigen-specific CD8⁺ T-cell responses during influenza infection or vaccination. CEF26 supports studies of epitope presentation, adaptive immune recognition, cellular immune profiling, and T-cell receptor repertoire analysis. It is commonly applied in ELISPOT, tetramer staining, intracellular cytokine assays, and cytotoxicity experiments. This influenza-derived peptide is a valuable tool for immune monitoring and vaccine research in HLA-matched models.

Product Name: CEF26, Influenza Virus NP (265-274)

Sequence One Letter Code: ILRGSVAHK

Sequence Three Letter Code: H-Ile-Leu-Arg-Gly-Ser-Val-Ala-His-Lys-OH

Chemical Formula:C43H77N15O11

Molecular Weight: 980.2

Purity: ≥ 95%

Form: Lyophilized

Storage Conditions: - 20 °C

Source / Species: Influenza

Conjugation: Unconjugated

Code Nacres: NA.26